All news articles for January 2013

DMAA blamed for London marathon death

DMAA in the dock

DMAA blamed for London marathon death

By Shane STARLING

A single dose of the banned stimulant DMAA was the most probable cause of the heart attack that killed Claire Squires in hospital after she collapsed during the final metres of the 2012 London marathon.

EU novel foods wrap: Clubmoss, omega-3 oils and zeaxanthin

EU novel foods wrap: Clubmoss, omega-3 oils and zeaxanthin

The UK Food Standards Agency is assessing two novel food applications for clubmoss sporopollenin shell extracts and a novel omega-3 and omega-6 oil; while DSM is lauding the official EU recognition of nature-identical zeaxanthin.

Beast of bureaucracy makes logjam hard to avoid

Straight talk

Beast of bureaucracy makes logjam hard to avoid

By RJ Whitehead

If there’s one thing India doesn’t need, that’s more bureaucracy. As the saying goes, the British introduced it, then the Indians perfected it post-Independence. And even as the country celebrated its sixty-fourth Republic day last week, all the form-filling...

Lutein pills may boost night vision: RCT

Lutein pills may boost night vision: RCT

By Stephen DANIELLS

Daily supplements of lutein may improve vision and help with tasks such as driving at night, say data from a randomized, double-blind, placebo-controlled trial.

Euromonitor “shocked” by EU probiotic decline

Euromonitor “shocked” by EU probiotic decline

By Shane Starling

After years and even decades of healthy to rampant growth in the European Union, the probiotics sector has entered decline, with a flat economy and health claim ban seen as the likely culprits.

UK raises food supplement questions with EC

UK raises food supplement questions with EC

By Shane Starling

UK Secretary of State for Health Jeremy Hunt has raised the controversial topic of maximum permitted levels (MPLs) of nutrients in food supplements in the EU with new EC health commissioner, Tonio Borg, Westminster has been told.

Probi 2012 sales up 6%, but ProViva royalties set for dive

Probi 2012 sales up 6%, but ProViva royalties set for dive

By Shane Starling

The European probiotic sector is bracing itself for tough times ahead in the wake of December’s  EU health claim ban for the sector, but the effects are yet to be felt at Swedish supplier Probi which notched 6% sales growth in 2012.

Chobani’s global ambitions: Too much, too young?

EDITOR'S OPINION: DEAR DAIRY....

Chobani’s global ambitions: Too much, too young?

By Mark Astley

At just seven years old, Chobani is a poster boy in the eyes of some, a market-devouring monster in the eyes of others. The New York-based Greek yogurt giant’s expansion plans in North America, Europe and Australasia are ambitious. But is it taking on...

Zinc to benefit from health claims game

Special edition: Innovations in minerals

Zinc benefitting from EU health claims game

By Shane Starling

Used in cigarette filters, as a corrosive, pigment and in the manufacture of rubber and concrete, zinc forms like zinc oxide and zinc suphate are also important nutrients for physiological wellbeing. And 18 new European Union health claims – the most...

EC: New botanical laws may take “5-6 years to implement

Brussels conference blog

Botanical sabbaticals, special cases, and the EU's legal Eldorado

By Shane STARLING

The ongoing imbroglio around botanical health claim regulation in the EU saw no sign of resolution in Brussels yesterday as the EC’s Basil Mathioudakis said any new regulatory framework could take “5-6 years” to become reality. Quite a sabbatical before...

Are vitamin D levels linked to mental health?

Are vitamin D levels linked to mental health?

By Stephen Daniells

Low levels of vitamin D may be associated with an increased risk of depression in mid-life, says a new study from University College London in the UK.

USPLabs sets aside $2m to settle DMAA class action cases

USPLabs sets aside $2m to settle DMAA class action cases

By Elaine WATSON

After a tidal wave of lawsuits and months of heated debate about the regulatory status of the stimulant DMAA (1,3-Dimethylamylamine), USPLabs has agreed to settle a nationwide class action suit challenging the legality and safety of its top-selling DMAA...

Follow us

Products

View more

Webinars